Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Revenue

Ironwood Pharmaceuticals had revenue of $41.14M in the quarter ending March 31, 2025, a decrease of -45.05%. This brings the company's revenue in the last twelve months to $317.68M, down -23.18% year-over-year. In the year 2024, Ironwood Pharmaceuticals had annual revenue of $351.41M, down -20.63%.

• Revenue (ttm): $317.68M
• Revenue Growth: -23.18%
• P/S Ratio: 0.34
• Revenue / Employee: $1,255,636
• Employees: 253
• Market Cap: 110.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	351.41M	-91.33M	-20.63%
Dec 31, 2023	442.74M	32.14M	7.83%
Dec 31, 2022	410.60M	-3.16M	-0.76%
Dec 31, 2021	413.75M	24.23M	6.22%
Dec 31, 2020	389.52M	-38.89M	-9.08%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.